Description of the national situation of cervical cancer screening in the member states of the European Union

This publication has 54 references indexed in Scilit:

• What’s next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination
  European Journal Of Cancer, 2009
• The current state of introduction of HPV vaccination into national immunisation schedules in Europe: Results of the VENICE 2008 survey
  European Journal Of Cancer, 2009
• Cervical cancer screening policies and coverage in Europe
  European Journal Of Cancer, 2009
• The challenges of organising cervical screening programmes in the 15 old member states of the European Union
  European Journal Of Cancer, 2009
• Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial
  The Lancet Oncology, 2008
• Results at Recruitment From a Randomized Controlled Trial Comparing Human Papillomavirus Testing Alone With Conventional Cytology as the Primary Cervical Cancer Screening Test
  JNCI Journal of the National Cancer Institute, 2008
• Estimates of the cancer incidence and mortality in Europe in 2006
  Annals of Oncology, 2007
• Human Papillomavirus Testing and Liquid-Based Cytology: Results at Recruitment From the New Technologies for Cervical Cancer Randomized Controlled Trial
  JNCI Journal of the National Cancer Institute, 2006
• The cervical cancer epidemic that screening has prevented in the UK
  The Lancet, 2004
• Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients
  British Journal of Cancer, 2003